Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma 29Hodgkin Disease 20Recurrence 4Lymphoma, Non-Hodgkin 4Neurotoxicity Syndromes 3Lymphoma, Follicular 3Lymphoma, Mantle-Cell 2Lymphoma, AIDS-Related 2Radiation Injuries 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1Intraocular Lymphoma 1HIV Infections 1Central Nervous System Neoplasms 1Burkitt Lymphoma 1

Interventions

Cyclophosphamide 12Vincristine 10Doxorubicin 10Etoposide 8Rituximab 6Prednisone 6Cytarabine 6Dexamethasone 5Bleomycin 5Zidovudine 4Methotrexate 4Leucovorin 4Filgrastim 4Peripheral Blood Stem Cell Transplantation 3sargramostim 2fludarabine phosphate 2fludarabine 2Whole-Body Irradiation 2Vinblastine 2Polymerase Chain Reaction 2Melphalan 2Dacarbazine 2Carmustine 2Antiretroviral Therapy, Highly Active 2Allopurinol 2prednylidene 1pembrolizumab 1liposomal doxorubicin 1ibrutinib 1efavirenz 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
HIV Infections × Procarbazine × Lymphoid × Clear all
NCT00822120 2022-08-18

S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma

SWOG Cancer Research Network

Phase 2 Completed
371 enrolled 14 charts
Lymphoid

Hodgkin Disease, Lymphoma, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡